| Follow Us: Facebook Twitter



3626 W Liberty St
Ann Arbor, MI 48103



Chris Gibbons

Chris Gibbons is the president & COO of HistoSonics, an Ann Arbor-based medical device company.

Read More

HistoSonics is a medical device company that is developing Histotripsy, a non-invasive image guided and robotic tissue ablation technology that was licensed from the University of Michigan. Histotripsy is a versatile platform that will replace traditional surgical and minimally invasive methods to reduce patient trauma and health care costs. The first clinical application will be treatment of Benign Prostatic Hyperplasia, a prevalent condition in senior men. The condition affects over two million men in the US and approximately 400,000 are treated surgically each year.

Related Content

U-M 1st in research spending, sets new tech records

The University of Michigan continues to serve as a pipeline for new economy research, start-ups, and the innovations they need to be successful. U-M has recently been declared No. 1 for R&D spending among the nation's public universities. That sort of investment has helped the university launch 10 start-ups, license 97 technologies, and record 290 new inventions over the last fiscal year. "The record (for new start-ups) is 13, but we average nine," says Ken Nisbet, executive director of office of Tech Transfer at the University of Michigan. "Ten isn't a record, but with the economy this year we are really proud of that number."The number of new technology licenses ties a record at U-M, which was set four years ago. And the 10 start-ups this year brings the university's total to 93 over the last decade. The university estimates those start-ups have created more than 2,000 jobs over the last 15 years. The start-ups include Histosonics, which was spun out of the university last year. The Ann Arbor-based company employs about a dozen people and has locked down $11 million in seed capital. HistoSonics (histo meaning tissue and sonics meaning sound waves) is developing a medical device that uses tightly focused ultrasound pulses to treat prostate disease. The idea is to create a non-invasive, image-guided system that can destroy tissue with robotic precision."It just has tremendous potential," Nisbet says.U-M plans to display some of its new start-ups and inventions at its annual Celebrate Invention reception between 3-6 p.m. today in the Michigan League Ballroom. For information, click here or reach Diane Brown at (734) 936-1572 or [email protected]Source: Ken Nisbet, executive director of office of Tech Transfer at the University of MichiganWriter: Jon Zemke read on…
Signup for Email Alerts